About Dylan Sammut
Dylan joined Irving Levin in October 2018 as a Research and Editorial Associate and is responsible for reporting on mergers and acquisitions in the healthcare sector. He graduated from Alfred University in May 2014 with a degree in English and Political Science. He currently lives in Bridgeport, CT with his fiancé and his overweight cat, Kimba, and in his free time he plays video games, reads, writes, and hikes on the weekends all year around.
by Dylan Sammut | Apr 12, 2021 10:35 am | Healthcare M&A News Leads
Rebound might be an understatement. After the healthcare M&A market slowed down for most of 2020 due to the pandemic, deal activity has roared back in the first quarter of 2021, with a staggering 596 deals on the books, a 17% increase compared to the 509 deals... Read More »
by Dylan Sammut | Apr 6, 2021 8:01 am | Healthcare Market Updates
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date... Read More »
by Dylan Sammut | Apr 5, 2021 11:23 am | eHealth
The national telehealth provider SOC Telemed has announced a new deal for Access Physicians valued at $194 million upfront with additional potential consideration based on performance. Access Physicians is an experienced multi-specialty acute inpatient telemedicine... Read More »
by Dylan Sammut | Apr 5, 2021 11:18 am | Pharmaceuticals, SPAC
If you were looking for another SPAC deal this week, say no more. Procaps Group announced a reverse merger with Union Acquisition Corp. II (NASDAQ: LATN). Founded in 1977, Procaps is a leading integrated international healthcare and pharmaceutical company with a... Read More »
by Dylan Sammut | Apr 5, 2021 11:08 am | Medical Devices
Early in March 2020, Merck & Co., Inc. (NYSE: MRK) announced the spin-off of a new company focused on women’s health. The new company, Organon & Co., will have a portfolio of more than 60 trusted medicines that address an entire spectrum of conditions that... Read More »